# Jochen K. Lennerz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jochen-k-lennerz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,916 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 74 |
| i10-index | 224 |
| Last Known Institution | Addgene |
| OpenAlex ID | https://openalex.org/A5067299042 |
| ORCID iD | 0000-0003-2434-4978 |
| Works | 629 |

## Researcher papers

Showing 12 of 13.

- [A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells](https://scholariq.org/papers/a-key-role-for-autophagy-and-the-autophagy-gene-atg16l1-in-mouse-and-human/)
- [A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity](https://scholariq.org/papers/a-human-natural-killer-cell-subset-provides-an-innate-source-of-il-22-for/)
- [Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer](https://scholariq.org/papers/molecular-mechanisms-of-resistance-to-first-and-second-generation-alk-inhibitors/)
- [COVID-19-neutralizing antibodies predict disease severity and survival](https://scholariq.org/papers/covid-19-neutralizing-antibodies-predict-disease-severity-and-survival/)
- [Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma](https://scholariq.org/papers/polyclonal-secondary-i-fgfr2-i-mutations-drive-acquired-resistance-to-fgfr/)
- [Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation](https://scholariq.org/papers/clinical-acquired-resistance-to-krasg12c-inhibition-through-a-novel-kras-switch/)
- [Origins of lymphatic and distant metastases in human colorectal cancer](https://scholariq.org/papers/origins-of-lymphatic-and-distant-metastases-in-human-colorectal-cancer/)
- [An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background](https://scholariq.org/papers/an-ultraviolet-radiation-independent-pathway-to-melanoma-carcinogenesis-in-the/)
- [Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i> -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion](https://scholariq.org/papers/landscape-of-acquired-resistance-to-osimertinib-in-i-egfr-i-mutant-nsclc-and/)
- [<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib](https://scholariq.org/papers/i-met-i-amplification-identifies-a-small-and-aggressive-subgroup-of/)
- [Clinicopathologic Features of Non–Small-Cell Lung Cancer Harboring an <i>NTRK</i> Gene Fusion](https://scholariq.org/papers/clinicopathologic-features-of-non-small-cell-lung-cancer-harboring-an-i-ntrk-i/)
- [The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer](https://scholariq.org/papers/the-clinical-landscape-of-cell-free-dna-alterations-in-1671-patients-with/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [Addgene](https://scholariq.org/institutions/addgene/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.